-
U-M stem cell trial to enter crucial phase
The first clinical trial using stem cells in Lou Gehrig's disease patients soon will begin testing the safety of the procedure in an area of the spine that eventually could be life-saving.
The landmark trial aims to slow progression of the fatal disease, also known as amyotrophic lateral sclerosis, or ALS, by injecting millions of stem cells into patients.